Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study intends to determine if any correlation exists between administration of TXA or
not to musculoskeletal oncology patients undergoing endoprosthetic reconstruction and blood
loss and blood transfusion rates.